| Title: |
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial |
| Authors: |
Eggermont, Alexander MM a, b, ⁎, 1, 2; Kicinski, Michal c; Blank, Christian U. d; Mandala, Mario e; Long, Georgina V. f; Atkinson, Victoria g; Dalle, Stéphane h; Haydon, Andrew i; Meshcheryakov, Andrey j; Khattak, Adnan k; Carlino, Matteo S. l; Sandhu, Shahneen m; Larkin, James n; Puig, Susana o; Ascierto, Paolo A. p; Rutkowski, Piotr q; Schadendorf, Dirk r; Boers-Sonderen, Marye s; Di Giacomo, Anna Maria t; van den Eertwegh, Alfonsus JM u; Grob, Jean-Jacques v; Gutzmer, Ralf w; Jamal, Rahima x; van Akkooi, Alexander C.J. y; Lorigan, Paul z; Grebennik, Dmitri aa; Kreplere, Clemens aa; Marreaud, Sandrine c; Suciu, Stefan c; Robert, Caroline ab |
| Source: |
In European Journal of Cancer November 2024 211 |
| Database: |
ScienceDirect |